A novel null homozygous mutation confirms CACNA2D2 as a gene mutated in epileptic encephalopathy

Tommaso Pippucci, Antonia Parmeggiani, Flavia Palombo, Alessandra Maresca, Andrea Angius, Laura Crisponi, Francesco Cucca, Rocco Liguori, Maria Lucia Valentino, Marco Seri, Valerio Carelli

Research output: Contribution to journalArticle

35 Citations (Scopus)

Abstract

Contribution to epileptic encephalopathy (EE) of mutations in CACNA2D2, encoding α2δ-2 subunit of Voltage Dependent Calcium Channels, is unclear. To date only one CACNA2D2 mutation altering channel functionality has been identified in a single family. In the same family, a rare CELSR3 polymorphism also segregated with disease. Involvement of CACNA2D2 in EE is therefore not confirmed, while that of CELSR3 is questionable. In a patient with epilepsy, dyskinesia, cerebellar atrophy, psychomotor delay and dysmorphic features, offspring to consanguineous parents, we performed whole exome sequencing (WES) for homozygosity mapping and mutation detection. WES identified extended autozygosity on chromosome 3, containing two novel homozygous candidate mutations: c.1295delA (p.Asn432fs) in CACNA2D2 and c.G6407A (p.Gly2136Asp) in CELSR3. Gene prioritization pointed to CACNA2D2 as the most prominent candidate gene. The WES finding in CACNA2D2 resulted to be statistically significant (p = 0.032), unlike that in CELSR3. CACNA2D2 homozygous c.1295delA essentially abolished α2δ-2 expression. In summary, we identified a novel null CACNA2D2 mutation associated to a clinical phenotype strikingly similar to the Cacna2d2 null mouse model. Molecular and statistical analyses together argued in favor of a causal contribution of CACNA2D2 mutations to EE, while suggested that finding in CELSR3, although potentially damaging, is likely incidental.

Original languageEnglish
Article numbere82154
JournalPLoS One
Volume8
Issue number12
DOIs
Publication statusPublished - Dec 16 2013

Fingerprint

encephalopathy
Brain Diseases
Genes
Exome
mutation
Mutation
Calcium Channels
Chromosomes
Polymorphism
genes
dyskinesia
calcium channels
prioritization
epilepsy
homozygosity
atrophy
Chromosomes, Human, Pair 3
Dyskinesias
animal models
Atrophy

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Pippucci, T., Parmeggiani, A., Palombo, F., Maresca, A., Angius, A., Crisponi, L., ... Carelli, V. (2013). A novel null homozygous mutation confirms CACNA2D2 as a gene mutated in epileptic encephalopathy. PLoS One, 8(12), [e82154]. https://doi.org/10.1371/journal.pone.0082154

A novel null homozygous mutation confirms CACNA2D2 as a gene mutated in epileptic encephalopathy. / Pippucci, Tommaso; Parmeggiani, Antonia; Palombo, Flavia; Maresca, Alessandra; Angius, Andrea; Crisponi, Laura; Cucca, Francesco; Liguori, Rocco; Valentino, Maria Lucia; Seri, Marco; Carelli, Valerio.

In: PLoS One, Vol. 8, No. 12, e82154, 16.12.2013.

Research output: Contribution to journalArticle

Pippucci, T, Parmeggiani, A, Palombo, F, Maresca, A, Angius, A, Crisponi, L, Cucca, F, Liguori, R, Valentino, ML, Seri, M & Carelli, V 2013, 'A novel null homozygous mutation confirms CACNA2D2 as a gene mutated in epileptic encephalopathy', PLoS One, vol. 8, no. 12, e82154. https://doi.org/10.1371/journal.pone.0082154
Pippucci T, Parmeggiani A, Palombo F, Maresca A, Angius A, Crisponi L et al. A novel null homozygous mutation confirms CACNA2D2 as a gene mutated in epileptic encephalopathy. PLoS One. 2013 Dec 16;8(12). e82154. https://doi.org/10.1371/journal.pone.0082154
Pippucci, Tommaso ; Parmeggiani, Antonia ; Palombo, Flavia ; Maresca, Alessandra ; Angius, Andrea ; Crisponi, Laura ; Cucca, Francesco ; Liguori, Rocco ; Valentino, Maria Lucia ; Seri, Marco ; Carelli, Valerio. / A novel null homozygous mutation confirms CACNA2D2 as a gene mutated in epileptic encephalopathy. In: PLoS One. 2013 ; Vol. 8, No. 12.
@article{4e579089b10545f39bea4fc99f87cf55,
title = "A novel null homozygous mutation confirms CACNA2D2 as a gene mutated in epileptic encephalopathy",
abstract = "Contribution to epileptic encephalopathy (EE) of mutations in CACNA2D2, encoding α2δ-2 subunit of Voltage Dependent Calcium Channels, is unclear. To date only one CACNA2D2 mutation altering channel functionality has been identified in a single family. In the same family, a rare CELSR3 polymorphism also segregated with disease. Involvement of CACNA2D2 in EE is therefore not confirmed, while that of CELSR3 is questionable. In a patient with epilepsy, dyskinesia, cerebellar atrophy, psychomotor delay and dysmorphic features, offspring to consanguineous parents, we performed whole exome sequencing (WES) for homozygosity mapping and mutation detection. WES identified extended autozygosity on chromosome 3, containing two novel homozygous candidate mutations: c.1295delA (p.Asn432fs) in CACNA2D2 and c.G6407A (p.Gly2136Asp) in CELSR3. Gene prioritization pointed to CACNA2D2 as the most prominent candidate gene. The WES finding in CACNA2D2 resulted to be statistically significant (p = 0.032), unlike that in CELSR3. CACNA2D2 homozygous c.1295delA essentially abolished α2δ-2 expression. In summary, we identified a novel null CACNA2D2 mutation associated to a clinical phenotype strikingly similar to the Cacna2d2 null mouse model. Molecular and statistical analyses together argued in favor of a causal contribution of CACNA2D2 mutations to EE, while suggested that finding in CELSR3, although potentially damaging, is likely incidental.",
author = "Tommaso Pippucci and Antonia Parmeggiani and Flavia Palombo and Alessandra Maresca and Andrea Angius and Laura Crisponi and Francesco Cucca and Rocco Liguori and Valentino, {Maria Lucia} and Marco Seri and Valerio Carelli",
year = "2013",
month = "12",
day = "16",
doi = "10.1371/journal.pone.0082154",
language = "English",
volume = "8",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "12",

}

TY - JOUR

T1 - A novel null homozygous mutation confirms CACNA2D2 as a gene mutated in epileptic encephalopathy

AU - Pippucci, Tommaso

AU - Parmeggiani, Antonia

AU - Palombo, Flavia

AU - Maresca, Alessandra

AU - Angius, Andrea

AU - Crisponi, Laura

AU - Cucca, Francesco

AU - Liguori, Rocco

AU - Valentino, Maria Lucia

AU - Seri, Marco

AU - Carelli, Valerio

PY - 2013/12/16

Y1 - 2013/12/16

N2 - Contribution to epileptic encephalopathy (EE) of mutations in CACNA2D2, encoding α2δ-2 subunit of Voltage Dependent Calcium Channels, is unclear. To date only one CACNA2D2 mutation altering channel functionality has been identified in a single family. In the same family, a rare CELSR3 polymorphism also segregated with disease. Involvement of CACNA2D2 in EE is therefore not confirmed, while that of CELSR3 is questionable. In a patient with epilepsy, dyskinesia, cerebellar atrophy, psychomotor delay and dysmorphic features, offspring to consanguineous parents, we performed whole exome sequencing (WES) for homozygosity mapping and mutation detection. WES identified extended autozygosity on chromosome 3, containing two novel homozygous candidate mutations: c.1295delA (p.Asn432fs) in CACNA2D2 and c.G6407A (p.Gly2136Asp) in CELSR3. Gene prioritization pointed to CACNA2D2 as the most prominent candidate gene. The WES finding in CACNA2D2 resulted to be statistically significant (p = 0.032), unlike that in CELSR3. CACNA2D2 homozygous c.1295delA essentially abolished α2δ-2 expression. In summary, we identified a novel null CACNA2D2 mutation associated to a clinical phenotype strikingly similar to the Cacna2d2 null mouse model. Molecular and statistical analyses together argued in favor of a causal contribution of CACNA2D2 mutations to EE, while suggested that finding in CELSR3, although potentially damaging, is likely incidental.

AB - Contribution to epileptic encephalopathy (EE) of mutations in CACNA2D2, encoding α2δ-2 subunit of Voltage Dependent Calcium Channels, is unclear. To date only one CACNA2D2 mutation altering channel functionality has been identified in a single family. In the same family, a rare CELSR3 polymorphism also segregated with disease. Involvement of CACNA2D2 in EE is therefore not confirmed, while that of CELSR3 is questionable. In a patient with epilepsy, dyskinesia, cerebellar atrophy, psychomotor delay and dysmorphic features, offspring to consanguineous parents, we performed whole exome sequencing (WES) for homozygosity mapping and mutation detection. WES identified extended autozygosity on chromosome 3, containing two novel homozygous candidate mutations: c.1295delA (p.Asn432fs) in CACNA2D2 and c.G6407A (p.Gly2136Asp) in CELSR3. Gene prioritization pointed to CACNA2D2 as the most prominent candidate gene. The WES finding in CACNA2D2 resulted to be statistically significant (p = 0.032), unlike that in CELSR3. CACNA2D2 homozygous c.1295delA essentially abolished α2δ-2 expression. In summary, we identified a novel null CACNA2D2 mutation associated to a clinical phenotype strikingly similar to the Cacna2d2 null mouse model. Molecular and statistical analyses together argued in favor of a causal contribution of CACNA2D2 mutations to EE, while suggested that finding in CELSR3, although potentially damaging, is likely incidental.

UR - http://www.scopus.com/inward/record.url?scp=84892960345&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84892960345&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0082154

DO - 10.1371/journal.pone.0082154

M3 - Article

VL - 8

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 12

M1 - e82154

ER -